CNTMD Statistics
Total Valuation
CNTMD has a market cap or net worth of 42.59 million. The enterprise value is 56.72 million.
| Market Cap | 42.59M |
| Enterprise Value | 56.72M |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTMD has 5.32 million shares outstanding. The number of shares has increased by 279.20% in one year.
| Current Share Class | 5.32M |
| Shares Outstanding | 5.32M |
| Shares Change (YoY) | +279.20% |
| Shares Change (QoQ) | +65.53% |
| Owned by Insiders (%) | 20.53% |
| Owned by Institutions (%) | 2.16% |
| Float | 2.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| PB Ratio | 27.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.49 |
| EV / Sales | 1.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.25, with a Debt / Equity ratio of 8.84.
| Current Ratio | 0.25 |
| Quick Ratio | 0.19 |
| Debt / Equity | 8.84 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -30.75% |
| Return on Invested Capital (ROIC) | -166.65% |
| Return on Capital Employed (ROCE) | -369.22% |
| Weighted Average Cost of Capital (WACC) | 83.03% |
| Revenue Per Employee | 200,206 |
| Profits Per Employee | -90,754 |
| Employee Count | 182 |
| Asset Turnover | 1.46 |
| Inventory Turnover | 41.15 |
Taxes
| Income Tax | -16,086 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.79% in the last 52 weeks. The beta is 18.82, so CNTMD's price volatility has been higher than the market average.
| Beta (5Y) | 18.82 |
| 52-Week Price Change | -60.79% |
| 50-Day Moving Average | 7.90 |
| 200-Day Moving Average | 7.55 |
| Relative Strength Index (RSI) | 52.79 |
| Average Volume (20 Days) | 2,737 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, CNTMD had revenue of 35.84 million and -16.25 million in losses. Loss per share was -7.19.
| Revenue | 35.84M |
| Gross Profit | 11.47M |
| Operating Income | -12.04M |
| Pretax Income | -16.07M |
| Net Income | -16.25M |
| EBITDA | -11.15M |
| EBIT | -12.04M |
| Loss Per Share | -7.19 |
Balance Sheet
The company has 2.90 million in cash and 13.93 million in debt, with a net cash position of -11.02 million or -2.07 per share.
| Cash & Cash Equivalents | 2.90M |
| Total Debt | 13.93M |
| Net Cash | -11.02M |
| Net Cash Per Share | -2.07 |
| Equity (Book Value) | 1.58M |
| Book Value Per Share | -0.32 |
| Working Capital | -24.74M |
Cash Flow
| Operating Cash Flow | -9.79M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 891,675 |
| Net Borrowing | 9.20M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 31.99%, with operating and profit margins of -33.59% and -45.33%.
| Gross Margin | 31.99% |
| Operating Margin | -33.59% |
| Pretax Margin | -44.85% |
| Profit Margin | -45.33% |
| EBITDA Margin | -31.10% |
| EBIT Margin | -33.59% |
| FCF Margin | n/a |
Dividends & Yields
CNTMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -279.20% |
| Shareholder Yield | -279.20% |
| Earnings Yield | -38.14% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 20, 2026. It was a reverse split with a ratio of 0.03125.
| Last Split Date | Apr 20, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.03125 |
Scores
CNTMD has an Altman Z-Score of -2.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.95 |
| Piotroski F-Score | 4 |